dna bytes · fusion genomics produces the world’s first ... fusion genomics. the dna diagnosis...

DNA BYTES

Fusion is pleased to welcome

Akmal Jameel to our man-

agement team as the new

CFO. Akmal brings a wealth

of experience in financial

management of start-ups.

In This Issue

Milestone Achieved

Share Price Increase

World’s First Child-

hood Cancer NGS

Test

Introducing Our New

CFO

ONETesttm for Influ-

enza Fusion Genomics produces the World’s First Childhood Cancer NGS Test

Funding Milestone Exceeded! Fusion is pleased to announce that our first round of seed funding is complete.

We sought C$ 500K and actually received C$ 580K, eighty thousand more than

we were asking for. Thanks to all our investors who helped us reach and exceed

this goal!

Share Values Increase 3-fold! The C$ 580K was raised at C$ 0.50 per share, a 3-fold increase from our initial

Friends and Family round last year, and a 2-fold increase from our Extended Fam-

ily and Friends Round.

Interim Funding Round

In our next round of funding we will be seeking C$ 650K (US$ 500K) at C$ 1.30

(US$ 1.00) per share.

Full Funding Round for US$ 2.3 - 3.0M

Our next full funding round will seek ~ US$ 3M.

World’s First Childhood Cancer NGS Test Fusion’s ChildSeq-Sarcoma ONETesttm is the world’s first test for childhood can-

cers that uses Next Generation Sequencing to identify the gene fusion responsible

for causing the cancer in a child with a sarcoma.

Fusion Genomics Corporation September 2015

Contact Us

Give us a call for more in-

formation about our ser-

vices and products

Fusion Genomics

8999 Nelson Way

Burnaby BC, V5A 4W9

Canada

(604) 428-7701

info@fusiongenomics.com

Visit us on the web at

www.fusiongenomics.com

ONETesttm

for Influenza Strains In order to stop the spread of influenza and prevent Infuenza outbreaks and pan-

demics, clinicians need to know which strain is infecting humans. Once the strain

is known, facilities can produce the necessary vaccine and it can be administered

to uninfected people to help boost their immunity to the flu.

We are in the final stages of developing a ONETesttm kit that tests for all strains of

human influenza virus and requires only a simple non-invasive nasopharyngeal

swab to obtain the patient sample needed for library construction, target-capture

and Next Generation Sequencing. Results are achieved in approximately 48

hours. A manuscript describing the entire process is being prepared for publica-

tion within the next few months.

ONETesttm results show this patient is H1N1

Fusion Genomics, Inc.

8999 Nelson Way

Burnaby BC, V5A 4W9

Fusion Genomics

8999 Nelson Way

PLACE STAMP HERE

Fusion Genomics. The DNA Diagnosis Company

Influenza Subtypes

0

2000

4000

6000

H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 H11 H12 H13 H14 H15 H16 BH

0

4000

8000

12000

16000

N1 N2 N3 N4 N5 N6 N7 N8 N9 BN